Previous close | 0.6200 |
Open | 0.7000 |
Bid | 0.5000 |
Ask | 0.7500 |
Strike | 5.00 |
Expiry date | 2026-01-16 |
Day's range | 0.6200 - 0.7000 |
Contract range | N/A |
Volume | |
Open interest | 67 |
SANTA MONICA, Calif., June 26, 2024--Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-pocket prescription spending trends in the U.S. to help Americans better understand prescription affordability and price transparency. Helping Americans get the healthcare they need starts with tackling the barriers of costs and coverage, and there are three key factors driving the financial burden for pre
SANTA MONICA, Calif., May 30, 2024--GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced the election of Simon Patterson to its Board of Directors. Currently leading EMEA operations for the technology investment firm Silver Lake, Mr. Patterson brings to GoodRx decades of technology, strategy and management experience. Mr. Patterson also serves on the boards of IVC Evidensia, New Zealand Rugby Commercial, RAC, and ZPG, and previously served on the b
SANTA MONICA, Calif., May 30, 2024--Today, GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. This is the second time GoodRx has received this honor for helping Americans get the medications they need at a price they can afford.